Bio-Path Holdings Expands Global Patent Portfolio NEWS: $BPTH Bio-Path Holdings Expands Global Patent PortfolioHOUSTON, April 15, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced the receipt of newl...
BPTH - Bio-Path Holdings Expands Global Patent Portfolio